REMKX
Price
$17.92
Change
+$0.06 (+0.34%)
Updated
Dec 20 closing price
RNWFX
Price
$77.72
Change
+$0.12 (+0.15%)
Updated
Dec 20 closing price
Ad is loading...

REMKX vs RNWFX

Header iconREMKX vs RNWFX Comparison
Open Charts REMKX vs RNWFXBanner chart's image
Victory Sophus Emerging Markets R
Price$17.92
Change+$0.06 (+0.34%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$77.72
Change+$0.12 (+0.15%)
VolumeN/A
CapitalizationN/A
REMKX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
REMKX vs. RNWFX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REMKX is a StrongBuy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 62.2B vs. REMKX (352M). REMKX pays higher dividends than RNWFX: REMKX (2.10) vs RNWFX (1.51). REMKX was incepted earlier than RNWFX: REMKX (24 years) vs RNWFX (23 years). REMKX is a more actively managed with annual turnover of: 72.00 vs. RNWFX (32.00). REMKX has a lower initial minimum investment than RNWFX: REMKX (0) vs RNWFX (250). REMKX annual gain was more profitable for investors over the last year : 7.57 vs. RNWFX (5.86). RNWFX return over 5 years is better than : 14.39 vs. REMKX (-1.43).
REMKXRNWFXREMKX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years23 years-
Gain YTD5.8284.549128%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets352M62.2B1%
Annual Yield % from dividends2.101.51139%
Returns for 1 year7.575.86129%
Returns for 3 years-8.12-5.10159%
Returns for 5 years-1.4314.39-10%
Returns for 10 years22.9342.6754%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS12.520.39
+3.22%
Viatris
TEO11.890.14
+1.19%
Telecom Argentina SA
DX12.570.14
+1.13%
Dynex Capital
INTT7.680.04
+0.52%
inTEST Corp
VIRX0.21N/A
-1.87%
Viracta Therapeutics